Revolutionizing Email Duplication Identification: EDRM MIH Integration with Nuix Neo

Introduction 

As of July 2023, Nuix Neo comes standard with EDRM Message Identification Hash (EDRM MIH) support. In an era where efficiency and accuracy are paramount, the world of eDiscovery and legal professionals has witnessed a groundbreaking innovation: the EDRM MIH. This revolutionary specification, introduced by EDRM on January 11, 2023, is a game-changer that promises to transform the way we identify duplicate emails across various platforms.

Nuix: A New Approach to Insider Threat

The recent arrest of a Samsung Electronics executive for theft of trade secrets1 was another grim reminder of a problem lurking quietly inside most modern organizations: misconduct by employees. Those who don’t focus on this topic, often referred to as “insider threat” in the United States, may be surprised to know it hides in the two top business risks that global organizations face today.

Meet your Nuix expert: Empowering Success Through Expertise

From the front lines how Nuix Advantage enhances your operations 

Introducing Paul Henshaw, Head of Solutions and a key member of the Advantage team at Nuix.  

In this interview, we dive into Paul's background, examine the approaches he utilizes to address and resolve customer challenges, and gain insights into the emerging technology trends that are shaping the future of investigations and eDiscovery. 

Jonathan Rubinsztein

Executive Director and Group Chief Executive Officer
Jonathan Rubinsztein

Jonathan has been the Group Chief Executive Officer since December 2021.  He is a seasoned CEO with a track record of building world class global technology companies and leading high-performance teams in the technology sector.

Sara Watts

Non-Executive Director
Sara Watts

Sara joined the Nuix Board in January 2023. 

Sara is a Non-Executive Director and Audit Committee Chair with experience across a range of sectors. In addition to Nuix, Sara currently serves on the boards of Syrah Resources (ASX:SYR) since June 2019, Trajan Scientific and Medical (ASX:TRJ) since March 2021, Uniting NSW. ACT, the Sydney Opera House Trust and the National Anti-Corruption Commission’s audit committee.   

Sir Iain Lobban

Non-Executive Director
Sir Iain Lobban

Iain has been an adviser to the Board since October 2018 and was appointed as a Non Executive Director of the Company in November 2020. Iain lives in the United Kingdom.